Platelet therapy

Indian Journal of Pediatrics

Volumn 69, Issue 9, 2002, Pages 779-783

  Choudhry, V P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bleeding; Platelet; Thrombocytopenia

Indexed keywords

CHILD; FEMALE; HOSPITALIZATION; HUMAN; INDIA; MALE; METHODOLOGY; PRESCHOOL CHILD; PROGNOSIS; REVIEW; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; MALE; PLATELET COUNT; PLATELET TRANSFUSION; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0036725983     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723692     Document Type: Review

References (42)

1. Hersh EM, Bodey GP, Nies BA, Freireich EJ. Causes of death in acute leukemia. JAMA 1965; 193 : 105-109.
2. Alvarado J, Djerassi I, Farber S. Transfusion of fresh concentrated platelets to children with acute leukemia. J Pediatr 1965; 67 : 13-22.
3. Cavins JA, Farber S, Roy AJ. Transfusion of fresh platelet concentrates to adult patients with thrombocytopenia. Transfusion 1968; 8 : 24-27.
4. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine 1976; 55 : 259-268.
5. Harrington WJ, Minnich V, Hollingsworth J, Moore CV. Demonstration of thrombocytopenic factor in blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38 : 1-10.
6. McMillan R, Longmire RL, Yelenosky BS et al. Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura. N Engl J Med 1972; 286 : 681-684.
7. Choudhry VP, Sharma LM, Kashyap R. Current concepts in pathogenesis and management of disseminated intravascular coagulation. In Gupte S, ed. Recent Advances in Pediatrics. Jaypee Brothers (Accepted for publication).
8. Aster RH. Pooling of platelets in the spleen : role in the pathogenesis of hypersplenic thrombocytopenia. J Clin Invest 1966; 45 : 645-657.
9. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patents with acute leukemia. N Engl J Med 1962; 26 : 905-909.
10. Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 1978; 7 : 523-529.
11. Slichter SJ. Controversies in platelet transfusion therapy. Annu Rev Med 1980; 31 : 509-540.
12. Freireich EJ, Kliman A, Gaydos LA et al. Response to repeated platelet transfusions from the same donor. Ann Intern Med 1963; 59 : 277-287.
13. Consensus Development Conference. Platelet transfusions. JAMA 1987; 257 : 1777-1780.
14. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287 : 155-159.
15. Rodgers RP, Levin JA. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 1 : 1-20.
16. De Caterina R, Lanza M, Manca G et al. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 194; 84 : 3363-3370.
17. Daly PA, Schiffer CA, Aisner J, Wiernik PH. Platelet transfusion therapy : one hour post transfusion increments are valuable in predicting the need for HLA matched preparations. JAMA 1980; 243 : 435-438.
18. Roy AJ, Jaffe N, Djerassi I. Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion 1973; 13 : 283-353.
19. Solomon J, Bofenkamp T, Fahey JL et al. Platelet prophylaxis in acute nonlymphoblastic leukemia. Lancet 1978; 1 : 267.
20. Murphy S, Litwin S, Herring LM et al. Indications for platelet transfusions in children with acute leukemia. Am J Hematol 1982; 12 : 347.
21. Fresh-Frozen plasma, Cryoprecipitate, and Platelet Administration Practice Guidelines Development Taks Force of the College of American Pathologists. Practice Parameter for the use of fresh - frozen plasma, cryoprecipitate and platelets. JAMA 1994; 271 : 777-781.
22. Novatny VMJ. Prevention and Management of platelet transfusion refractoriness. Vox Sang 1999; 76 : 1-13.
23. Dutcher JP, Schiffer CA, Aisner J, Wiernik PH. Alloimmunization following platelet transfusions the absence of a dose response relationship. Blood 1981; 37 : 395-398.
24. Klingemann HG, Self S, Banaji M et al. Refractoriness to random donor platelet transfusions in patients with aplastic anemia: a multivariate analysis of data from 264 cases. Br J Haematol 1987; 66 : 115-121.
25. Brand A. White cell depletion: Why and how? In Nance SJ, ed. Transfusion Medicine in the 1990's, Arlington, American Association of Blood Banks, 1990; 35-61.
26. Gmur J, von Folten A, Osterwalder B et al. Delayed alloimmunization using single donor platelet transfusion: a prospective study in thrombocytpenic patients with acute leukemia. Blood 1983; 62 : 473-479.
27. Eernisse JG, Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Haematol 1981; 9 : 77-83.
28. Andreu G, Dewailly J. Prevention of HLA alloimmunization by using leukocyte-depleted components. Curr Stud Hematol Blood Transfus 1994; 60 : 29-40.
29. Novotny VMJ, van Doorn R, Witvliet MD, Claas FHJ, Brand A. Occurrence of allogeneic HLA and non - HLA antibodies after transfusion of prestorage filtered platelet and red blood cells : A prospective study. Blood 1995; 85 : 1738-1741.
30. Van Marwijk Kooy M, van Pooyen HC, Moes M, Bosma-Stants I, Akkerman JWN. Use of leukocyte depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective randomized trial. Blood 1991; 77 : 201-205.
31. Sichter SJ. The trial to reduce alloimmunization to platelets study group. Leukocyte reduction and ultraviolet B irradiation of plateletls to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337 : 1861-1869.
32. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays N et al. A comparison of filtered leukocyte reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion associated CMV-infection after marrow transplants. Blood 1995; 86 : 3595-3603.
33. Muylle L, Joos M, Wouters E, de Bock R, Peetermans ME. Increased tumor necrosis factor α (TNF-α interleukin 1 & interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates. Relationship between TNF-α and IL-6 levels and febrile transfusion reactions. Transfusion 1993; 33 : 195-199.
34. Morroff G, Garraty G, Heal JM, MacPheo BR, Stroneck D et al. Selection of platelets for refractory patients-HLA matching and prospective crossmatching. Transfusion 1992; 32 : 633-637.
35. Gelib AB, Leavitt AD. Crossmatch compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 1997; 37 : 624-630.
36. Bussel JB, Pham LC, Aledort L, Nachman. Maintenance treatment of adults with refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72 : 121-127.
37. Choudhry VP, Kashyap R. Idiopathic thrombocytopenia purpura (ITP) in Recent Advances in Pediatrics. In Gupte S, ed. Hematology. Jaypee Brothers 2000; 7 : 144-155.
38. Kickler T, Braine HG, Piantadosi S, Ness PM, Herman JH, Rothko K. A randomized placebo controlled trial of intravenous gammalgobulin in alloimmunized thrombocytopenic patients. Blood 1990; 75 : 313-316.
39. Besinger WI, Buckner CD, Clift RA, Slichter SJ, Thomas ED. Plasma exchange for platelet alloimmunization. Transplantation 1986; 41 : 602-605.
40. Gutensohn K, Zander AR, Rowley SD, Hester J, Kuchne P. Protein A immunoadsorption in alloimunized patients refractory to platelets transfusions and in patients with treatment resistant thrombocytopenic purpura. Transfus Sci 1998; 19 : 47-52.
41. Novotny VMJ, Doxiadis INN, van Doorn R, Brand A. The kinetics of HLA class I elution and the relevance for the use of HLA-eluted platelet transfusions. Br J Haematol 1996; 95 : 416-422.
42. Castro E, Muncumill J, Barea L, Gonzalez R, Fernandez Villalta MJ. Acid - elution of platelets HLA - class I antigens in the treatment of a refractory patient. Br J Hematol 1998; 100 : 245-246.